These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1140850)

  • 1. Chromosomal synthesis of staphylococcal exfoliative toxin.
    Keyhani M; Rogolsky M; Wiley BB; Glasgow LA
    Infect Immun; 1975 Jul; 12(1):193-7. PubMed ID: 1140850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of extrachromosomal deoxyribonucleic acid for exfoliative toxin production from phage group II Staphylococcus aureus.
    Warren R; Rogolsky M; Wiley BB; Glasgow LA
    J Bacteriol; 1975 Apr; 122(1):99-105. PubMed ID: 123526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature of the genetic determinant controlling exfoliative toxin production in Staphylococcus aureus.
    Rogolsky M; Warren R; Wiley BB; Nakamura HT; Glasgow LA
    J Bacteriol; 1974 Jan; 117(1):157-65. PubMed ID: 4271807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage group II staphylococcal strains with chromosomal and extrachromosomal genes for exfoliative toxin production.
    Rogolsky M; Wiley BB; Glasgow LA
    Infect Immun; 1976 Jan; 13(1):44-52. PubMed ID: 129438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcal scalded-skin syndrome: development of a primary binding assay for human antibody to the exfoliative toxin.
    Wiley BB; Glasgow LA; Rogolsky M
    Infect Immun; 1976 Feb; 13(2):513-20. PubMed ID: 131109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and serological differentiation of staphylococcal exfoliative toxin synthesized under chromosomal and plasmid control.
    Wiley BB; Rogolsky M
    Infect Immun; 1977 Nov; 18(2):487-94. PubMed ID: 411758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal and extrachromosomal synthesis of exfoliative toxin from Staphylococcus hyicus.
    Sato H; Watanabe T; Higuchi K; Teruya K; Ohtake A; Murata Y; Saito H; Aizawa C; Danbara H; Maehara N
    J Bacteriol; 2000 Jul; 182(14):4096-100. PubMed ID: 10869090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New type of exfoliatin obtained from staphylococcal strains, belonging to phage groups other than group II, isolated from patients with impetigo and Ritter's disease.
    Kondo I; Sakurai S; Sarai Y
    Infect Immun; 1974 Oct; 10(4):851-61. PubMed ID: 4139120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative and quantitative methods for detecting staphylococcal epidermolytic toxin.
    Arbuthnott JP; Billcliffe B
    J Med Microbiol; 1976 May; 9(2):191-201. PubMed ID: 819654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcal scalded skin syndrome: potentiation by immunosuppression in mice; toxin-mediated exfoliation in a healthy adult.
    Wiley BB; Allman S; Rogolsky M; Norden CW; Glasgow LA
    Infect Immun; 1974 Apr; 9(4):636-40. PubMed ID: 4822864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on toxinogenesis in Vibrio cholerae. III. Characterization of nontoxinogenic mutants in vitro and in experimental animals.
    Holmes RK; Vasil ML; Finkelstein RA
    J Clin Invest; 1975 Mar; 55(3):551-60. PubMed ID: 803978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and some properties of staphylococcal alpha-toxin.
    Watanabe M; Kato I
    Jpn J Exp Med; 1974 Apr; 44(2):165-78. PubMed ID: 4546168
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification of exfoliatin produced by Staphylococcus aureus of bacteriophage group 2 and its physicochemical properties.
    Kondo I; Sakurai S; Sarai Y
    Infect Immun; 1973 Aug; 8(2):156-64. PubMed ID: 4269383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ethidium bromide on elimination of exfoliative toxin and bacteriocin production in Staphylococcus aureus.
    Warren R; Rogolsky M; Wiley BB; Glasgow LA
    J Bacteriol; 1974 Jun; 118(3):980-5. PubMed ID: 4829933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of a staphylococcal epidermolytic toxin.
    Dimond RL; Wuepper KD
    Infect Immun; 1976 Feb; 13(2):627-33. PubMed ID: 1262065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exfoliative toxin plasmids of bacteriophage group 2 Staphylococcus aureus: sequence homology.
    Warren RL
    Infect Immun; 1980 Nov; 30(2):601-6. PubMed ID: 6254889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of exfoliative toxin from Staphylococcus intermedius and its local toxicity in dogs.
    Terauchi R; Sato H; Hasegawa T; Yamaguchi T; Aizawa C; Maehara N
    Vet Microbiol; 2003 Jun; 94(1):19-29. PubMed ID: 12742712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production, purification, and chemical characterization of Staphylococcus aureus exfoliative toxin.
    Johnson AD; Metzger JF; Spero L
    Infect Immun; 1975 Nov; 12(5):1206-10. PubMed ID: 1193729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial characterization of aerolysin, a lytic exotoxin from Aeromonas hydrophila.
    Bernheimer AW; Avigad LS
    Infect Immun; 1974 Jun; 9(6):1016-21. PubMed ID: 4208526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.
    Eklund MW; Poysky FT
    Appl Microbiol; 1974 Jan; 27(1):251-8. PubMed ID: 4589131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.